Cargando…

Effects of Bilwa-Lajadi syrup in emesis gravidarum – an exploratory single arm open labeled trial

BACKGROUND: Emesis gravidarum is a common obstetrical problem affecting 50–80% of pregnant women during their first trimester which begins in the morning and frequently continues throughout the day; considered as one of the Vyakta Garbha Lakshana in Ayurveda. If it is not treated effectively in time...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Deepika, Asokan, Vasudevan, Bhat NV, Gayathri, Jain, Prathima, HL, Kavyashree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814406/
https://www.ncbi.nlm.nih.gov/pubmed/35033423
http://dx.doi.org/10.1016/j.jaim.2021.08.015
_version_ 1784645050320289792
author Singh, Deepika
Asokan, Vasudevan
Bhat NV, Gayathri
Jain, Prathima
HL, Kavyashree
author_facet Singh, Deepika
Asokan, Vasudevan
Bhat NV, Gayathri
Jain, Prathima
HL, Kavyashree
author_sort Singh, Deepika
collection PubMed
description BACKGROUND: Emesis gravidarum is a common obstetrical problem affecting 50–80% of pregnant women during their first trimester which begins in the morning and frequently continues throughout the day; considered as one of the Vyakta Garbha Lakshana in Ayurveda. If it is not treated effectively in time; it may lead to complications in pregnancy affecting the quality of life and thus the pregnancy outcome. OBJECTIVE: To evaluate the clinical effectiveness of Bilwa-Lajadi syrup in emesis gravidarum. MATERIAL AND METHODS: A single arm open labeled clinical trial was conducted on 30 participants fulfilling the inclusion criteria from OPD and IPD of Prasuti Tantra Evam StreeRoga, Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan and administered with Bilwa-Lajadi Syrup 20 ml per day in two divided doses, empty stomach before food for 30 days with followed up every 15 days during treatment and 15 days after completion of trial period. RESULTS: The drug showed statistically significant effect in reducing the frequency of vomiting per day, quantity of vomitus, aversion to smell, nausea and anorexia, altered content of vomitus, improved appetite, imparted lightness of body and increased haemoglobin gm%. CONCLUSION: Thus, early medication with Bilwa-Lajadi syrup and following dietetic regimen played a vital role in relieving the symptoms of emesis gravidarum.
format Online
Article
Text
id pubmed-8814406
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88144062022-02-08 Effects of Bilwa-Lajadi syrup in emesis gravidarum – an exploratory single arm open labeled trial Singh, Deepika Asokan, Vasudevan Bhat NV, Gayathri Jain, Prathima HL, Kavyashree J Ayurveda Integr Med Original Research Article BACKGROUND: Emesis gravidarum is a common obstetrical problem affecting 50–80% of pregnant women during their first trimester which begins in the morning and frequently continues throughout the day; considered as one of the Vyakta Garbha Lakshana in Ayurveda. If it is not treated effectively in time; it may lead to complications in pregnancy affecting the quality of life and thus the pregnancy outcome. OBJECTIVE: To evaluate the clinical effectiveness of Bilwa-Lajadi syrup in emesis gravidarum. MATERIAL AND METHODS: A single arm open labeled clinical trial was conducted on 30 participants fulfilling the inclusion criteria from OPD and IPD of Prasuti Tantra Evam StreeRoga, Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan and administered with Bilwa-Lajadi Syrup 20 ml per day in two divided doses, empty stomach before food for 30 days with followed up every 15 days during treatment and 15 days after completion of trial period. RESULTS: The drug showed statistically significant effect in reducing the frequency of vomiting per day, quantity of vomitus, aversion to smell, nausea and anorexia, altered content of vomitus, improved appetite, imparted lightness of body and increased haemoglobin gm%. CONCLUSION: Thus, early medication with Bilwa-Lajadi syrup and following dietetic regimen played a vital role in relieving the symptoms of emesis gravidarum. Elsevier 2022 2022-01-13 /pmc/articles/PMC8814406/ /pubmed/35033423 http://dx.doi.org/10.1016/j.jaim.2021.08.015 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Article
Singh, Deepika
Asokan, Vasudevan
Bhat NV, Gayathri
Jain, Prathima
HL, Kavyashree
Effects of Bilwa-Lajadi syrup in emesis gravidarum – an exploratory single arm open labeled trial
title Effects of Bilwa-Lajadi syrup in emesis gravidarum – an exploratory single arm open labeled trial
title_full Effects of Bilwa-Lajadi syrup in emesis gravidarum – an exploratory single arm open labeled trial
title_fullStr Effects of Bilwa-Lajadi syrup in emesis gravidarum – an exploratory single arm open labeled trial
title_full_unstemmed Effects of Bilwa-Lajadi syrup in emesis gravidarum – an exploratory single arm open labeled trial
title_short Effects of Bilwa-Lajadi syrup in emesis gravidarum – an exploratory single arm open labeled trial
title_sort effects of bilwa-lajadi syrup in emesis gravidarum – an exploratory single arm open labeled trial
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814406/
https://www.ncbi.nlm.nih.gov/pubmed/35033423
http://dx.doi.org/10.1016/j.jaim.2021.08.015
work_keys_str_mv AT singhdeepika effectsofbilwalajadisyrupinemesisgravidarumanexploratorysinglearmopenlabeledtrial
AT asokanvasudevan effectsofbilwalajadisyrupinemesisgravidarumanexploratorysinglearmopenlabeledtrial
AT bhatnvgayathri effectsofbilwalajadisyrupinemesisgravidarumanexploratorysinglearmopenlabeledtrial
AT jainprathima effectsofbilwalajadisyrupinemesisgravidarumanexploratorysinglearmopenlabeledtrial
AT hlkavyashree effectsofbilwalajadisyrupinemesisgravidarumanexploratorysinglearmopenlabeledtrial